Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reissued by research analysts at Liberum Capital in a report issued on Monday. They presently have a GBX 8,000 ($108.49) price objective on the stock. Liberum Capital’s price objective would indicate a potential upside of 17.60% from the stock’s current price.

A number of other equities research analysts also recently issued reports on the stock. UBS Group set a GBX 7,000 ($94.93) price target on shares of Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Thursday. JPMorgan Chase & Co. reissued an “overweight” rating and issued a GBX 7,500 ($101.71) price target on shares of Reckitt Benckiser Group in a research note on Wednesday, January 10th. Morgan Stanley set a GBX 9,000 ($122.05) price target on shares of Reckitt Benckiser Group and gave the company a “buy” rating in a research note on Tuesday, January 9th. Kepler Capital Markets reduced their price target on shares of Reckitt Benckiser Group from GBX 7,300 ($99.00) to GBX 7,000 ($94.93) and set a “hold” rating on the stock in a research note on Monday, January 8th. Finally, Goldman Sachs Group set a GBX 7,070 ($95.88) price target on shares of Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Monday, December 11th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of GBX 7,664.55 ($103.94).

Reckitt Benckiser Group (LON RB) traded up GBX 0.60 ($0.01) during trading on Monday, hitting GBX 6,802.60 ($92.25). 663,260 shares of the stock were exchanged, compared to its average volume of 1,170,000. The stock has a market cap of $47,870.00 and a P/E ratio of 2,275.12. Reckitt Benckiser Group has a twelve month low of GBX 6,299 ($85.42) and a twelve month high of GBX 8,110.43 ($109.99).

In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah purchased 2,285 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The stock was purchased at an average price of GBX 6,567 ($89.06) per share, for a total transaction of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The shares were acquired at an average price of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34).

ILLEGAL ACTIVITY NOTICE: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/15/reckitt-benckiser-group-rb-given-buy-rating-at-liberum-capital.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.